Perindopril tab 2 mg and 4 mg: Brand change
Perindopril is a long-acting ACE inhibitor. Your brand is changing from Apo-Perindopril to Coversyl.
27 July 2021 Update
Delisting date for Apo-Perindopril added.
Your new brand: Coversyl
We are advised that stocks of Apo-Perindopril (supplied by Apotex) may be exhausted during February. Accordingly, we have listed the Coversyl brand from 1 February 2021 to ensure a funded brand remains available.
Coversyl has the same active ingredient which is delivered to the body in the same way. This product will be supplied under provisional consent.
The Coversyl brand is listed and fully funded from 1 February 2021.
Coversyl is currently supplied with packaging for the Canadian market. Medsafe have written to health professionals about the differences between the Canadian packaging and New Zealand's requirements.
Apotex leaving the market
As Apotex is leaving New Zealand, we are arranging new suppliers for the medicines they had supplied.
Apo-Perindopril to be delisted 1 October 2021
Both presentations of Apo-Perindopril will be delisted from the Pharmaceutical Schedule on 1 October 2021.
Who to contact
If you take perindopril, ask your health care professional if you have any questions about this brand change. They know you and your clinical circumstances best.
If you have any funding questions, email email@example.com